Skip to main content

KAMES CAPITAL plc

Position in ABBV — AbbVie Inc.

CIK 1539994 EDINBURGH, X0

Position in ABBV

as of Jun 30, 2026 · filed Jul 13, 2026
Position Value
$171,298,897
+$62,804,446 QoQ
Shares Held
680,730
+36.5% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
1.88%
of 13F equity value
Holder Rank
#4
of 427 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 81.03932543005303.ToString("F0")% Shared 0.ToString("F0")% None 18.96067456994697.ToString("F0")%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

KAMES CAPITAL plc holds $1,010,877,249 across 9 Drug Manufacturers - General names. ABBV ranks #2 (16.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 ABBV
AbbVie Inc.
This page
680,730 $171,298,897

All Filings in ABBV

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $171,298,897 680,730
2026-03-31 $108,494,451 498,848
2025-12-31 $115,027,121 503,423
2025-09-30 $121,204,706 523,472
2025-06-30 $109,619,747 590,560
2025-03-31 $122,729,692 585,766
2024-12-31 $88,472,387 497,875
2024-09-30 $95,366,646 482,918
2024-06-30 $84,100,200 490,323
2024-03-31 $78,243,271 429,672
2023-12-31 $4,593,620 29,642
2023-06-30 $3,242,277 24,065
2023-03-31 $4,402,596 27,625
2022-12-31 $4,960,457 30,694
2022-09-30 $3,236,876 24,118
2022-06-30 $3,922,887 25,613
2022-03-31 $4,314,071 26,612
2021-12-31 $4,488,239 33,148
2021-09-30 $3,496,390 32,413
2021-06-30 $4,191,447 37,211
2021-03-31 $4,026,974 37,211
2020-12-31 $4,154,312 38,771
2020-09-30 $3,395,951 38,771
2020-06-30 $2,935,483 29,899
2020-03-31 $1,059,345 13,904